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2 Shared last authorship.ABCA3 mutations cause fatal surfactant deﬁciency and interstitial lung disease. ABCA3 protein is a
lipid transporter indispensible for surfactant biogenesis and storage in lamellar bodies (LB). The
protein folds in endoplasmic reticulum and is glycosylated in Golgi en route to the membrane of
mature LB and their precursor multivesicular bodies (MVB). In immunoblots, C-terminally labeled
ABCA3 appears as two protein bands of 150 and 190 kDa. Using N- and C-terminal protein tags
and hindering ABCA3 processing we show that the 150 kDa protein represents the mature ABCA3
whose N-terminus is cleaved by a cysteine protease inside MVB/LB.
Structured summary:
MINT-7996633: Calnexin (uniprotkb:P27824) and ABCA3 (uniprotkb:Q99758) colocalize (MI:0403) by
ﬂuorescence microscopy (MI:0416)
MINT-7996380, MINT-7996593, MINT-7996607: LAMP3 (uniprotkb:Q9UQV4) and ABCA3 (uniprotkb:
Q99758) colocalize (MI:0403) by ﬂuorescence microscopy (MI:0416)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction ABCA3 is a glycoprotein with two transmembrane domains andABCA3 is an ATP-binding cassette (ABC) transporter highly ex-
pressed in alveolar epithelial type II cells. It is localized to the lim-
iting membrane of lamellar bodies (LB), acidic and lipid rich
organelles for production, storage and regulated secretion of pul-
monary surfactant [1–4]. Surfactant is a phospholipid/protein mix-
ture which reduces surface tension and prevents alveolar collapse
at the end of expiration [5]. ABCA3 transports surfactant phospho-
lipids into LB and is essential for lamellar body biogenesis, surfac-
tant homeostasis and lung function [6,7]. Mutations of the ABCA3
gene impair folding, trafﬁcking and function of the transporter
[8–10], causing thereby respiratory distress and chronic interstitial
lung disease (ILD) [11–13].chemical Societies. Published by E
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energy for substrate transport [14]. On its maturation pathway
ABCA3 folds in the endoplasmic reticulum (ER) and is glycosylated
in the Golgi compartment. Finally, ABCA3 is directed to the acidic
lysosome-derived multivesicular bodies (MVB), precursor vesicles
of the mature LB [3,15]. ABCA3 is detectable in the limiting mem-
brane of both immature MVB and mature LB, together with other
proteins such as lysosome-associated membrane glycoprotein 3
(LAMP3) [3,7,16].
While in some related ATP-binding cassette transporters, the N-
terminus possibly directs the protein’s membrane insertion and
orientation and contains a potentially cleavable signal peptide
[17,18], processing of the N-terminus and its signiﬁcance for the
ABCA3 cell biology is unexplored. In immunoblots, C-terminally la-
beled ABCA3 gives two protein bands of 150 and 190 kDa [8,9,19].
It was suggested, however not experimentally proven, that the
150 kDa band might arise by proteolytic cleavage at the ABCA3
N-terminus [19]. Thus it is still unclear what the two ABCA3 forms
are and which one is the mature transporter. Within the same
MVB/LB acidic milieu, where ABCA3 is located, the proteolytic
cleavage is necessary for maturation of the hydrophobic surfactant
proteins (SP) SP-B and SP-C from the corresponding pro-proteins
and it is mediated by two protease classes: cysteine (cathepsin
H) and aspartyl (napsin A, pepsinogen C) proteases [16,20–24].
By application of N- and C-terminal protein tags and interferinglsevier B.V. All rights reserved.
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minus is proteolytically removed inside acidic LAMP3-positive ves-
icles MVB/LB, possibly with assistance of cysteine, but not aspartyl
proteases.Fig. 1. The lower 150/180 kDa ABCA3 band lacks the N-terminus and it accumu-
lates in stably transfected cells. ABCA3 was labeled with (A) C-terminal HA-tag
(1 kDa) and (B) C-terminal YFP (left) or N-terminal GFP (middle and right) (YFP/GFP
size – 30 kDa). While HA-tag labeled ABCA3 was either stably or transiently (48 h)
expressed in A549 cells (A), ABCA3 with YFP- or GFP-tag was expressed only
transiently for 48 h (B). Protein expression was detected by immunoblotting via the
tag-speciﬁc antibodies. b-Actin – a housekeeping protein.2. Materials and methods
2.1. Plasmid vectors
For the expression of ABCA3 with N-terminal GFP (GFPN-
ABCA3), full length wild type (WT) human hABCA3 cDNA [25]
was cloned into pEGFP-C1 plasmid (Clontech). pEYFP-N1 vector
(Clontech) with cloned WT hABCA3 cDNA (kindly provided by A.
Holzinger) was used for the expression of ABCA3 with C-terminal
YFP (ABCA3-YFPC). For the expression of ABCA3 with C-terminal
hemagglutinin tag (HA-tag) (ABCA3-HAC) hABCA3 cDNA was
cloned into the modiﬁed pUB6/V5-His vector (Invitrogen) with in-
serted HA-tag (kindly provided by M. Woischnik and N. Weichert).
Two ABCA3 point mutations Q215K and E292V were introduced
into WT hABCA3 by site-directed mutagenesis (Stratagene). For
the expression of proSP-C with N-terminal HA-tag (HAN-proSP-
C), hSP-C cDNA was cloned into the modiﬁed pUB6/V5-His vector
with inserted N-terminal HA-tag (Invitrogen).
2.2. Cell culture
Human lung epithelial cell line A549 (ACC 107) was transfected
at 70 % conﬂuence using ExGen 500 (Fermentas). Samples were
collected 48 h post transient transfection. A549 cells stably
expressing ABCA3-HAC or HAN-proSP-C were selected using 6 lg/
ml blasticidin for ﬁve weeks. Where indicated, stable cells were
incubated for 1, 5, 18 and 24 h with 10 lg/ml of brefeldin A,
2 lM monensin and 0.4 lM baﬁlomycin A1 or 10, 30 min, 1, 12
and 24 h with 10 lg/ml of cycloheximide (Sigma). Similarly, where
stated stable cells were incubated for 1, 5, 18 and 24 h with
100 lM, or 24 h with 1, 5, 10 and 100 lM of protease inhibitors
E-64 (trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane)
and pepstatin A (Sigma).
2.3. Immunoﬂuorescence
Immunoﬂuorescence was performed with the following pri-
mary antibodies: anti-LAMP3/CD63 (Chemicon), anti-calnexin
(Santa Cruz) or anti-HA-tag (Roche). Signals were visualized with
Alexa Fluor 488 and 555 secondary antibodies (Invitrogen). Fluo-
rescent signal was examined with Axiovert 135 ﬂuorescent micro-
scope (Carl Zeiss).
2.4. Immunoblotting
Cells were resuspended in lysis buffer (0.15 M NaCl, 1% Triton-
X100, 0.5% sodium deoxycholate, 50 mM Tris, 5 mM EDTA) sup-
plied with protease inhibitor (Complete; Roche). 30 lg of total pro-
tein were transferred to a PVDF membrane and immunoblotted
using anti-GFP/YFP (Clontech), anti-HA-tag (Roche) and anti-b-ac-
tin HRP conjugate (Santa Cruz). Chemiluminiscent signal was de-
tected by ECL Detection Reagents (GE Healthcare) and analyzed
by densitometry.
2.5. Statistical analyses
Statistics was performed by one-way ANOVA and Bonferroni’s
test using GraphPad Prism version 4.0 (GrapPad Software Inc.). Re-
sults were presented as means ± S.E.M of minimum three experi-
ments, p-values <0.05 were considered signiﬁcant.3. Results
3.1. The N-terminus is missing from the 150 kDa ABCA3 protein
Forty eight hour transient expression of ABCA3 coupled with
C-terminal HA-tag (ABCA3-HAC plasmid; size of HA tag – 1 kDa)
resulted in the appearance of two protein bands of 150 and
190 kDa in human A549 cells, as detected by immunoblotting with
anti-HA-tag antibody (Fig. 1A, right panel). Similarly, two protein
bands, only 30 kDa bigger (180 and 220 kDa) due to presence of
the 30 kDa yellow/green ﬂuorescent protein (YFP/GFP)-tag, were
immunodetected of ABCA3 with C-terminal YFP-tag (ABCA3-YFPC
plasmid) by anti-YFP/GFP antibody 48 h post transient transfection
(Fig. 1B, left). Therefore we conclude that ABCA3 expression is not
inﬂuenced by the protein tag used (HA or YFG/GFP), and neither is
ABCA3 intracellular localization, as presented later via immunoﬂu-
orescence in Figs. 3 and 4. However, an obvious feature of the 48 h
transient ABCA3 expression with C-terminal tag was a notably
weaker lower 150/180 kDa band when compared to the strongly
present higher 190/220 kDa bands (Fig. 1A right panel and
Fig. 1B left). On the other hand, stable expression of ABCA3 protein
with C-terminal HA tag in A549 cells (ABCA3-HAC plasmid)
strongly increased the protein amount of the lower 150 kDa band
(Fig. 1A, left panel). This indicates that the prolonged and consis-
tent ABCA3 expression in the stable cell line is necessary for accu-
mulation of the lower 150 kDa band. In contrast, limited 48 h
transient expression with either protein tag does not provide the
time necessary for accumulation of the ABCA3 lower band. There-
fore, the lower 150/180 kDa band could be the mature ABCA3 pro-
duced by proteolytic cleavage/s at the N-terminus of the 190/
220 kDa protein. To conﬁrm this conclusion we transiently ex-
pressed ABCA3 with N-terminal GFP-tag (GFPN-ABCA3 plasmid)
in A549 cells (Fig. 1B, middle and right). ABCA3 immunodetection
with anti-GFP/YFP antibody showed complete absence of the lower
180 kDa band indicating that this protein band indeed lacks the N-
terminus.
3.2. The 150 kDa ABCA3 protein appears post trans-Golgi in acidic
vesicles
To show that the 150 kDa band represents the mature ABCA3
originating from the 190 kDa protein, we successively blocked
the processing pathway of A549 cells stably expressing ABCA3-
HAC (Fig. 2) using brefeldin A, which disrupts the transport be-
tween ER and Golgi resulting in protein accumulation in the ER
Fig. 2. Sequential inhibition of the processing pathway (A) in A549 cells stably expressing ABCA3-HAC. Exposure to the antibiotics (B) brefeldin A (Bref), (C) monensin (Mon)
and (D) baﬁlomycin A1 (Baf), resulted in all cases in fading of the 150 kDa band and accumulation of the 190 kDa band with increasing incubation time. (E) Exposure to
cycloheximide (Chx), an inhibitor of protein translation, reduced the amount of the upper 190 kDa band while the lower band persisted. ABCA3 bands were immunodetected
with anti-HA-tag antibody in cell lysates. n.t. – Non-treated cells. b-Actin – a housekeeping protein. Results of three independent experiments are presented; *P < 0.05,
**P < 0.01, ***P < 0.001.
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accumulation of proteins within the Golgi [26,27], and baﬁlomy-
cin A1, an inhibitor of the vacuolar ATPase necessary for acidiﬁcat-
ion and function of secretory organelles like MVB and LB [15,28]
(Fig. 2A). Each of these three antibiotics caused accumulation of
the 190 kDa band and disappearance of the 150 kDa band during
the course of incubation (Fig. 2B–D). The inhibitor concentrations
used did not impair the general cell growth or ﬁtness (not shown).
Cycloheximide blocks mRNA translation and thereby de novo pro-
tein synthesis without impairing the processing of already synthe-
sized proteins [29]. As expected, cycloheximide treatment of A549
cells stably expressing ABCA3-HAC resulted in gradual fading of the
190 kDa band. The amount of the lower 150 kDa band persisted,
due to the processing of the synthesized ABCA3, and was still vis-
ible even after 12 and 24 h of the treatment (Fig. 2E). These results
conﬁrm that the 150 kDa protein is the mature ABCA3 produced by
cleavage of the 190 kDa form. Since the N-terminal cleavage and
appearance of the 150 kDa ABCA3 must take place in a cell com-
partment downstream from the point of action of the antibiotics
with inhibitory effect, we conclude that the cleavage happens post
trans-Golgi within MVB/LB as the ﬁnal intracellular ABCA3
destination.
3.3. The N-terminal tag on ABCA3 is detectable in LAMP3-positive
vesicles
If the 150 kDa band without N-terminus appears only after
ABCA3 reaches the membrane of LAMP3-positive immature MVB
and mature LB, as Fig. 2 suggests, the N-terminal protein tag on
ABCA3 should be detectable within these organelles. To examine
this, GFPN-ABCA3 and ABCA3-YFPC were transiently expressed inA549 cells (Fig. 3). Fluorescence of YFP fused to the ABCA3 C-termi-
nus localized clearly to the LAMP3-positive vesicles, in line with the
presence of the C-terminus in the mature ABCA3 form (Fig. 3B).
Likewise, the immunoﬂuorescence of HA-tag coupled to the ABCA3
C-terminus resulted in the same LAMP3-colocalization as the C-ter-
minal YFP (Fig. 4A). However, ﬂuorescent GFP signal at the ABCA3
N-terminus also colocalized with LAMP3 proving that ABCA3 still
contains the N-terminus at the moment when it reaches the
MVB/LB membrane (Fig. 3A). Therefore, the cleavage/s at the
ABCA3 N-terminusmust happen within the ABCA3 destination ves-
icles as the 150 kDa ABCA3 is missing the N-terminus (Fig. 1).
3.4. The ER retained ABCA3 mutant lacks the 150 kDa protein band
ABCA3 mutations cause either ABCA3 misfolding and ER reten-
tion by the ER quality control, or disrupt the function of ABCA3 cor-
rectly positioned in the LB membrane [8–10]. We used two ILD-
related ABCA3mutations (Supplementary Fig. 1): Q215K, a misfold-
ing defect studied here for the ﬁrst time, and E292V, a functional
mutation [10], to prove that the ER retention in general, regardless
of the cause (mutation as intrinsic cause or enforced processing
impairment, Fig. 2) hinders the ABCA3 maturation. Localization
studies in A549 cells stably expressing WT, Q215K or E292V pro-
teins with C-terminal HA-tag showed that the E292V mutant colo-
calized properly with the MVB/LB protein LAMP3 (Fig. 4A) but not
with the ER protein calnexin (Fig. 4B). Q215K mutant remained in
the ER compartment, overlapping with calnexin (Fig. 4B) and
showing no colocalization with LAMP3 (Fig. 4A). Immunodetection
of WT, Q215K and E292V proteins via HA-tag demonstrated that
the ER retained Q215K protein completely lacked the 150 kDa
band, which was strongly present in the MVB/LB-localized WT
Fig. 3. The ﬂuorescent signals of the ABCA3-bound (A) N-terminal GFP tag and (B) C-terminal YFP (both green) are detectable in LAMP3-positive vesicles (red). Calnexin
immunoﬂuorescence is the ER marker (red). Scale bars – 10 lm.
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of ABCA3, independent of the cause, hinders appearance of the
150 kDa protein.
3.5. Cysteine but not aspartyl proteases mediate the N-terminal ABCA3
cleavage
In the acid milieu of MVB/LB cysteine and aspartyl proteases
mediate the SP-B processing [20–23], whereas proSP-C processing
is mediated primary by the cysteine protease cathepsin H [24]. To
investigate if the same proteases inﬂuence the N-terminal ABCA3
cleavage and appearance of the 150 kDa band, stable A549
expressing ABCA3-HAC were treated with inhibitors of these prote-
ases (Fig. 5). Incubation with increasing concentrations or through
increasing times at a given concentration of the cysteine protease
inhibitor E-64 efﬁciently blocked the ABCA3 maturation, as moni-
tored through accumulation of the 190 kDa band and disappear-
ance of the 150 kDa band (Fig. 5A and B). However, neither
increasing inhibitor concentration nor increasing incubation time
affected the ABCA3 processing in the case of the aspartyl protease
inhibitor pepstatin A (Fig. 5C and D). Again, applied concentrations
of the protease inhibitors did not impair cell growth or vitality (not
shown). Similarly, processing of stably expressed proSP-C with
N-terminal HA tag (HAN-proSP-C) within A549 cells was efﬁciently
blocked by treatment with cysteine protease inhibitor E-64, result-
ing in accumulation of the proSP-C form (Supplementary Fig. 2).
We conclude that at least one class of MVB/LB-localized proteasesthat also participates in maturation of the surfactant proteins,
namely cysteine proteases, mediates the N-terminal cleavage of
the ABCA3 inside MVB/LB.
4. Discussion
In this study we investigated the processing of the human sur-
factant phospholipid transporter ABCA3 in cultured cells. By appli-
cation of protein tags, we showed that the higher 190/220 kDa
band (size dependent on the tag used) was detectable through both
C- and N-terminal protein tags, while the lower 150/180 kDa band
was detectable only via C-terminal, but not N-terminal tag (Fig. 1).
Stable expression of ABCA3-HAC with C-terminal HA-tag strongly
increased the protein amount of the lower 150 kDa band in com-
parison to the 48 h transient ABCA3 expression from the same
plasmid in the same cell type (Fig. 1A). Both indicate that the lower
band arises by N-terminal cleavage (one or more) of the higher
band, accumulates with the time of expression and could represent
the mature ABCA3. Similar results we obtained in human HEK293
cells, assuring that ABCA3 processing was independent of the cell
line (not shown). It must be mentioned that ABCA3 is a glycopro-
tein, but full ABCA3 deglycosylation with PNGase decreases the
size of the 190 kDa protein by only 10 kDa ([8,9], own data), imply-
ing that the size difference between the 150 and 190 kDa forms is
not solely their oligosaccharide content.
The successive blockage of the processing pathway with non-
toxic doses of three antibiotics [26–28] in the stable cells with
Fig. 4. The ER-retained Q215K mutant lacks the 150 kDa band. WT ABCA3 and two mutants E292V and Q215K (all C-terminal HA-tag) were stably expressed in A549 cells.
HA-tag immunoﬂuorescence of WT and E292V (green) showed their correct LAMP3-colocalization (A, red) while Q215K mutant (green) remained in the ER colocalizing with
calnexin (B, red). (C) ABCA3 immunodetection in cell lysates via anti-HA-tag antibody showed absence of the 150 kDa band in the case of the Q215K protein. b-Actin – a
housekeeping protein. Scale bars – 10 lm.
Fig. 5. Cysteine but not aspartyl proteases mediate the ABCA3 processing. A549 cells stably expressing ABCA3-HAC were incubated with (A and B) E-64 or (C and D) pepstatin
A, in the following manner: (A and C) with increasing protease inhibitor concentrations for 24 h, or (B and D) with 100 lM of the inhibitors through increasing incubation
time (as depicted). The ABCA3 processing was monitored via HA-tag immunodetection in cell lysates. n.t. – Non-treated cells. b-Actin – a housekeeping protein.
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product of the higher one (Fig. 2). It also identiﬁed the post-
trans-Golgi acidic vesicles (MVB/LB), dependent on the vacuolar
ATPase, as the intracellular compartment of the N-terminal cleav-
age, where the ﬂuorescent signal of the N-terminal GFP on GFPN-
ABCA3 was still detectable (Fig. 3). Moreover, strong ABCA3 ERretention caused by Q215K mutation resulted in vanishing of the
lower band (Fig. 4), showing that the effect was not speciﬁc only
for the chemical interference of the ABCA3 processing. The
decrease in the lower band intensity caused by the ABCA3 muta-
tions was previously mentioned [8] and it originates probably
from somewhat hindered maturation of the ABCA3 mutants. Yet,
S. Engelbrecht et al. / FEBS Letters 584 (2010) 4306–4312 4311complete absence of the lower band we noticed only in the case of
Q215K and other ER retained ABCA3 mutations (e.g. L101P; own
data, [8,9]).
The generation of the lower 150 kDa band appears to be neces-
sary for ABCA3 functionality, as evident through the inﬂuence on
biogenesis of LAMP3 positive vesicles in A549 cells. Biogenesis of
LB (or LAMP3-positive vesicles in A549 cells) is one of the most
important functions of ABCA3 protein. The ER retained mutation
Q215K, which completely lacks the 150 kDa band, does not support
the biogenesis of LAMP3-positive vesicles (Fig. 4, red signal) in A549
cells, while WT protein and even E292V mutant that has reduced
ATP hydrolysis capacity [10] both do. Thus it appears that the pres-
ence of only the 190 kDa band (as for Q215K mutant) within A549
cells is not enough for ABCA3 function, and thus ABCA3 maturation
is indispensible for its role. Instead accumulation of the lower
150 kDa band, a process that includes N-terminal cleavage, is nec-
essary for at least partial ABCA3 function (Fig. 4, E292V mutation).
The proteolytic processing of two essential surfactant compo-
nents, hydrophobic proteins SP-B and SP-C, happens also within
the acidic organelles MVB/LB [16,20–22], as the place of surfactant
biogenesis and storage, and can be chemically interfered similarly
as the ABCA3 processing [15]. The aspartyl and cysteine proteases
necessary for the maturation of surfactant speciﬁc proteins are
foundwithinMVBand LB.One could expect that the functionof such
enzymatic machinery in acidic vesicles extends also to other MVB/
LB localized proteins involved in surfactant homeostasis. In fact
we could show that the blockage of cysteine but not aspartyl prote-
ases with speciﬁc inhibitors impairs the ABCA3 processing (Fig. 5).
Similar N-terminal cleavage of the signal sequence has been pro-
posed for the cholesterol transporter ABCA1, but the published
sources do not agree on thismatter.While Tanaka et al. (2001) claim
the N-terminal cleavage within the ﬁrst extracellular loop [17],
Fitzgerald et al. (2001) describe a non-cleavable signal anchor se-
quence at the N-terminus of ABCA1 [18]. Nevertheless both groups
agree on importance of the N-terminus for ABCA1 intracellular tar-
geting and membrane insertion. In the case of ABCA3 N-terminal
cleavage has been until now only proposed [19]. With the tools
for signal peptides and cleavage site prediction SignalP 3.0 [30]
and Signal-3L [31] we could assign a N-terminal signal peptide to
ABCA3 and with small differences identify a potential cleavage site
to the beginning of the ﬁrst extracytoplasmic loop roughly between
residues 36 and 48. This loop is positioned toward the inside of
acidic vesicles and therefore exposed to the proteases-containing
environment of these organelles (Supplementary Fig. 1). However,
the exact cleavage site must be experimentally determined.
In conclusion, the 150 kDa protein band is possibly the mature
ABCA3 transporter produced by proteolytic processing at the N-
terminus. This cleavage is mediated by a cysteine protease within
MVB and LB as the ﬁnal intracellular ABCA3 destination and the
place of its function in surfactant biogenesis.
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